(Reuters) - Cipla Ltd, India's fourth-largest drugmaker by revenue, posted an about 7 percent rise in third-quarter net profit on Wednesday, but missed analysts' estimates.
Net profit rose to 4.01 billion rupees ($62.54 million) in the quarter ended Dec. 31, from 3.75 billion rupees a year earlier, the company said. http://bit.ly/2C1Sg7w
Analysts on average had expected a profit of 4.44 billion rupees, Thomson Reuters data showed.
($1 = 64.1150 Indian rupees)
(Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Christopher Cushing and Subhranshu Sahu)
Disclaimer: No Business Standard Journalist was involved in creation of this content
